Mechanistic role of RND3-regulated IL33/ST2 signaling on cardiomyocyte senescence
Authors:
- Kaijia ShiKSKaijia Shi
- Zhihua ShenZSZhihua Shen
- Junli GuoJGJunli Guo
- Wei JieWJWei Jie
Preprint
- 28 July 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
BACKGROUND: Hyperinflammatory responses are pivotal in the pathophysiology of cardiomyocyte senescence, with IL33 serving as a crucial pro-inflammatory mediator. Our previous findings highlighted RND3's suppressive effect on IL33 expression. This study delves into the influence of RND3 on IL33/ST2 signaling activation and cardiomyocyte senescence. METHODS: AC16 cardiomyocytes were subjected to treatments involving recombinant IL33, NF-κB inhibitor PDTC, or ST2 antibody Astegolimab. SA-β-gal and γH2AX staining were utilized to monitor alterations in cell senescence and DNA damage, respectively. Western blot analysis was conducted to ascertain the expression of Senescence-Associated Secretory Phenotype (SASP) and NF-κB activation. Utilizing CRISPR/Cas9 technology, the RND3 gene was knocked out in H9C2 cells, followed by senescence analysis and sST2 level detection in the culture medium supernatant via ELISA. Post-AAV9 injection overexpressing RND3 in SD rats, IL33/ST2 and SASP expression in heart tissues, and serum IL33 and sST2 changes were evaluated using ELISA. RESULTS: Exogenous IL-33 significantly induced IL-1α, IL6, and MCP1 expression, increased the p-p65/p65 ratio, and the proportion of SA-β-gal and γH2AX positive cells in AC16 cells. PDTC and Astegolimab application mitigated these effects. RND3 knockout in H9C2 cells led to increased intracellular IL33, ST2L, IL1 α, IL6, and MCP1 expression, decreased sST2 in the supernatant, and increased SA-β-gal and γH2AX positive cells. RND3 overexpression suppressed IL33, ST2L, IL-1α, IL6, and MCP1 expression in heart tissues, decreased serum IL33, and increased sST2 levels. CONCLUSION: RND3 expression in cardiomyocytes modulates cell senescence by negatively regulating the IL33/ST2/NF-κB signaling pathway, underscoring its potential as a therapeutic target in cardiovascular senescence.Keywords
All Related Versions
Funding Information
- Hainan Provincial Department of Science and Technology (ZDYF2022SHFZ038, ZDYF2020122)
- National Natural Science Foundation of China (82060053)
This publication has 34 references indexed in Scilit:
- Rnd3 as a Novel Target to Ameliorate Microvascular LeakageJournal of the American Heart Association, 2016
- Rnd3/RhoE Modulates Hypoxia-Inducible Factor 1α/Vascular Endothelial Growth Factor Signaling by Stabilizing Hypoxia-Inducible Factor 1α and Regulates Responsive Cardiac AngiogenesisHypertension, 2016
- Pathophysiological Functions of Rnd 3/ RhoE2015
- Genetic Deletion of Rnd3/RhoE Results in Mouse Heart Calcium Leakage Through Upregulation of Protein Kinase A SignalingCirculation Research, 2015
- ST2 may not be a useful predictor for incident cardiovascular events, heart failure and mortalityHeart, 2014
- Rnd3 haploinsufficient mice are predisposed to hemodynamic stress and develop apoptotic cardiomyopathy with heart failureCell Death & Disease, 2014
- Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculatureJournal of Molecular and Cellular Cardiology, 2013
- Interleukin-33 Drives a Proinflammatory Endothelial Activation That Selectively Targets Nonquiescent CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2013
- Interleukin-33 Induces Expression of Adhesion Molecules and Inflammatory Activation in Human Endothelial Cells and in Human Atherosclerotic PlaquesArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Coupling Vascular and Myocardial Inflammatory Injury into a Common Phenotype of Cardiovascular Dysfunction: Systemic Inflammation and Aging – A Mini-ReviewGerontology, 2010